|By Marketwired .||
|July 28, 2014 09:00 AM EDT||
DUBLIN, IRELAND -- (Marketwired) -- 07/28/14 -- Research and Markets (http://www.researchandmarkets.com/research/w7rp9l/invitro) has announced the addition of the "In-Vitro Toxicology/ Toxicity Testing Market by Industry, Technology, Applications & Method - Global Forecast to 2018" report to their offering.
The global market of in-vitro toxicology testing is subdivided into industry, technology, method, application and geography. On the basis of industry, the market is further segmented into diagnostics, pharmaceuticals, chemicals, cosmetics, and food. Diagnostics is further categorized into sample and type. The largest market share was captured by the pharmaceutical industry, whereas cosmetics industry was the fastest growing industry with a double digit CAGR. The prime factor contributing to the growth of pharmaceutical industry has been the attention towards the detection of toxicity during earlier stages of development.
On the basis of technology, the global market of in vitro toxicology testing is divided into cell culture, high throughput screening, cellular imaging, and omics technologies. Cell culture technology will witness the maximum growth rate in the coming years.
The methods considered for the study are cellular assays, biochemical assays, ex vivo and in silico. Cellular assays market is estimated to grow at a double digit CAGR during the forecast period (2013-2018). Cellular assays can predict the biological properties of potential drug compounds. These assays can also detect and measure cell viability, functionality and growth.
Under the applications, the market is segmented into systemic toxicity, dermal toxicity, ocular toxicity, endocrine disruption (reproductive & developmental toxicity) and others. Systemic toxicity testing was the largest segment in 2013. The increasing focus on detection of toxicity in earlier stages of development is leading to persistent requirement for human cell-based in vitro models for cardiotoxicity and liver toxicity testing which are the major reasons for drug attrition.
Europe commanded the largest share of the global market in 2013. This is attributed to the support provided by the European government for anti-animal testing laws. The government has further put ban on the production and sale of all animal tested cosmetics across the continent.
The market will be driven by increasing acceptance of in-vitro toxicology testing methods as alternatives to in vivo toxicology testing. The new technologies in the in vitro testing market help in investigating the adverse effects of environmental agents in a more mechanistic and time saving manner. Organizations such as REACH foresee that more results of in vitro and in silico methods will be included in risk assessment which will promote the use of in vitro methods for toxicology testing.
-- Diagnostic -- Pharmaceutical -- Cosmetics -- Chemical
-- Cell Culture -- HTS -- Omics
-- Systemic -- Dermal -- Ocular
-- Cellular Assay -- Ex vivo -- In Silico
Key Topics Covered:
1. Introduction 2. Executive Summary 3. Premium Insights 4. Market Overview 5. By Industry 6. By Technology 7. By Application 8. By Method 9. Geographic Analysis 10. Competitive Landscape 11. Company Profiles -- Agilent Technologies, Inc. -- Alere, Inc. -- Bio-Rad Laboratories, Inc. -- Bioreliance, Inc. -- Catalent -- Charles River Laboratories International, Inc. -- Covance, Inc. -- Cyprotex -- Eurofins Scientific -- GE Healthcare -- Life Technologies Corporation -- Quest Diagnostics
Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Biotechnology include:
-- IGEN Biotech Group -- BASF -- McKinsey & Company, Inc. -- Mitsubishi Research Institute, Inc. -- Beiersdorf AG -- NPS Pharmaceuticals, Inc. -- Vertex Pharmaceuticals -- Beckman Coulter Genomics -- Baxter Innovations GmbH -- Otsuka Pharmaceutical Company -- Bio Springer -- Qiagen -- Amgen -- Yale University
Research and Markets
Laura Wood, Senior Manager
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Dec. 3, 2016 04:30 PM EST Reads: 1,459
Dec. 3, 2016 04:00 PM EST Reads: 4,847
Dec. 3, 2016 03:30 PM EST Reads: 1,567
Dec. 3, 2016 03:15 PM EST Reads: 3,215
Dec. 3, 2016 03:00 PM EST Reads: 452
Dec. 3, 2016 02:45 PM EST Reads: 657
Dec. 3, 2016 02:45 PM EST Reads: 495
Dec. 3, 2016 02:45 PM EST Reads: 687
Dec. 3, 2016 02:45 PM EST Reads: 772
Dec. 3, 2016 02:15 PM EST Reads: 6,949
Dec. 3, 2016 02:00 PM EST Reads: 2,473
Dec. 3, 2016 02:00 PM EST Reads: 456
Dec. 3, 2016 01:30 PM EST Reads: 2,121
Businesses and business units of all sizes can benefit from cloud computing, but many don't want the cost, performance and security concerns of public cloud nor the complexity of building their own private clouds. Today, some cloud vendors are using artificial intelligence (AI) to simplify cloud deployment and management. In his session at 20th Cloud Expo, Ajay Gulati, Co-founder and CEO of ZeroStack, will discuss how AI can simplify cloud operations. He will cover the following topics: why clou...
Dec. 3, 2016 01:15 PM EST Reads: 612
Internet of @ThingsExpo, taking place June 6-8, 2017 at the Javits Center in New York City, New York, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo New York Call for Papers is now open.
Dec. 3, 2016 01:00 PM EST Reads: 1,865